All Type of News
Gradual recognition plans for licences in the KORUS FTA.
In the extraordinary session of National Assembly on July 26 the MOHW answered to the question raised by Rep. Lee Ki-woo about the health and medical policy for the KORUS FTA talks that the reciprocal recognition of t...
Drug registration system to be substantially reshuffled from Oct. 1.
The health registration system for drugs will be radically reshuffled from coming Oct. 1 according to the KFDA.
For this objective the KFDA already disclosed a draft of the revised registration provisions for manuf...
Positive list system to cause industries and patients heavy burdens.
The positive list system raises a controversial backlash in the pharmaceutical industry. After the government's advanced announcement of its legislation plan, the drug industry made a loud voice with slight different ...
AZ Korea to raise legal action on NHI price down.
AZ Korea raised a legal process against the NHI price down of Iressa, an anti lung cancer drug, for the injunction of the price down measures.
The MOHW earlier reduced 11% of NHI price for Iressa taking effect from...
Bukwang's clevudine to grab bigger market share
Bukwang Pharm is expected to expand its market share of the domestic anti-hepatitis B drug market dominated by GlaxoSmithKline (GSK), analysts said.
Clevudine, the first-domestically-made medication for hepatitis B...
National Assembly Ad hoc panel on FTA with US convened
A National Assembly ad hoc panel on free trade talks with the United States convened on July 31, officials at the Assembly's secretariat said.
Composed of 20 lawmakers, the ad hoc panel is aimed at formulating meas...
Korean, Japanese seek alliance in drug reviewing
The Korea Food and Administration (KFDA) said it will seek ways to enhance cooperation of drug reviewing with the Pharmaceutical Medical Device Agency (PMDA) in Japan over the long-term.
The Japanese Ministry of He...
Major pharmaceutical firm report strong profit in first half
Korea's major drug makers reported a strong net profit in the first half of this year, driven by robust sales of drugs and thrift management.
Dong-A Pharm earned 16.1 billion won in net profit for the first h...
Civic group calls for early introduction of new drug pricing policy
The Korean government will have to implement an earlier implementation of the so-called "positive list system" to cut the prices of medicines manufactured by foreign companies to reduce its soaring insurance coverage ...
New anti-hepatitis B drug to make debut in December
The Korea Food and Drug Administration (KFDA) approved a local pharmaceutical company's anti-hepatitis B drug on July 28 and the market for anti-hepatits B medicines dominated by imported drugs is expected to enter fi...
